Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Otorrinolaringología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Randomized Double-blind Placebo-controlled Parallel Group Study Assessing the Efficacy and Safety of Dupilumab in Patients With Allergic Fungal Rhinosinusitis (AFRS)
INTERVENTIONAL
Inicio: 1 de dic de 2020
ID: NCT04684524
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Multicentre Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Proxinium Plus Best Supportive Care Versus Best Supportive Care Alone in Patients With Advanced SCCHN Who Have Received at Least One Anti-cancer Treatment Regimen for Advanced Disease
INTERVENTIONAL
Inicio: 1 de dic de 2005
ID: NCT00412776
Reclutando
Fase 3
ClinicalTrials.gov
An Open-label Phase II/III Randomized Trial of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Monotherapy as a First Line Therapy in Patients With Unresectable Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Which is Positive for Human Papilloma Virus 16 (HPV16+) and Expresses PD-L1
INTERVENTIONAL
Inicio: 7 de ene de 2021
ID: NCT04534205
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Recurrent or Metastatic PD-L1+ Head and Neck Squamous Cell Carcinoma
INTERVENTIONAL
Inicio: 25 de sept de 2024
ID: NCT06525220
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
INTERVENTIONAL
Inicio: 12 de feb de 2025
ID: NCT06834347
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab in Participants With Inadequately Controlled Chronic Rhinosinusitis Without Nasal Polyps
INTERVENTIONAL
Inicio: 16 de dic de 2024
ID: NCT06691113
Desconocido
ClinicalTrials.gov
Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery: Comparative Study Between Perimodiolar and Lateral Wall Electrodes
OBSERVATIONAL
Inicio: 19 de jul de 2021
ID: NCT05079867
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin SR Versus Levofloxacin for the Treatment of Acute Bacterial Maxillary Sinusitis in Adults Undergoing Diagnostic Sinus Aspiration
INTERVENTIONAL
Inicio: 1 de ene de 2003
ID: NCT00643409
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-Blind, Placebo-Controlled, Multi-centre, Phase III Study of Post-Operative Adjuvant Lapatinib or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib or Placebo Monotherapy in High-Risk Subjects With Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00424255
Completado
Fase 3
ClinicalTrials.gov
Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00174837
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps
INTERVENTIONAL
Inicio: 6 de feb de 2025
ID: NCT06834360
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
INTERVENTIONAL
Inicio: 17 de jul de 2024
ID: NCT06454240
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-center, Open Label Study of NIR178 in Combination With PDR001 in Patients With Selected Advanced Solid Tumors and Non-Hodgkin Lymphoma
INTERVENTIONAL
Inicio: 28 de ago de 2017
ID: NCT03207867
Completado
Fase 3
ClinicalTrials.gov
The BURAN Study of Buparlisib (AN2025) In Combination With Paclitaxel Compared to Paclitaxel Alone, in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
INTERVENTIONAL
Inicio: 12 de dic de 2020
ID: NCT04338399
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy and MEDI4736 in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
INTERVENTIONAL
Inicio: 9 de sept de 2015
ID: NCT02369874
Completado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study
INTERVENTIONAL
Inicio: 30 de oct de 2023
ID: NCT06013241
Completado
Fase 3
ClinicalTrials.gov
A Randomized Phase III Multicenter Trial of Neoadjuvant Docetaxel (Taxotere®) Plus Cisplatin and 5-Fluorouracil (TPF) Versus Neoadjuvant Cisplatin Plus 5-Fluorouracil Followed by Concomitant Chemoradiotherapy to Improve the Overall Survival and Progression Free Survival in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
INTERVENTIONAL
Inicio: 1 de may de 1999
ID: NCT00273546
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dupilumab in Patients With Uncontrolled, Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP)
INTERVENTIONAL
Inicio: 2 de dic de 2020
ID: NCT04678856
Reclutando
Fase 2
ClinicalTrials.gov
A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study
INTERVENTIONAL
Inicio: 12 de may de 2025
ID: NCT06914908
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, 52-week, Placebo Controlled Efficacy and Safety Study of Dupilumab, in Patients With Bilateral Nasal Polyposis on a Background Therapy With Intranasal Corticosteroids
INTERVENTIONAL
Inicio: 28 de nov de 2016
ID: NCT02898454
Anterior
1
2
3
...
434
Siguiente
Filtros